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㩷 1) Yamamoto T., Fujiwara K., Yoshida M., Kageyama-Yahara N., Kuramoto H., Shibahara N., 
Kadowaki M.: Therapeutic Effect of Kakkonto in a Mouse Model of Food Allergy with 
Gastrointestinal Symptoms. 
International Archives of Allergy and Immunology 148: 175-185, 2008. 
㩷 Abstract: Background: The number of patients with food allergy has increased dramatically over the last 
several decades. However, there is no effective drug for food allergies. In the present study, we evaluated 
the effects of kakkonto, a traditional Japanese herbal medicine, in a mouse model of food allergy with 
gastrointestinal symptoms. Methods: BALB/c mice were systemically sensitized twice with ovalbumin 
(OVA) and then were repeatedly given OVA by oral intubation (OVA mice). Kakkonto was administered 
orally before the OVA challenges. Results: The OVA mice developed allergic diarrhea (91.8 ± 3.8% after 6 
OVA challenges), and myeloperoxidase (MPO) activity was dramatically elevated in the colons of the 
OVA mice. Kakkonto significantly suppressed the occurrence of allergic diarrhea and MPO activity in the 
OVA mice. Furthermore, the number of mucosal mast cells was greatly increased in the proximal colons of 
the OVA mice, and this was also suppressed by kakkonto. Interestingly, mRNA expression of helper T cell 
type 1 (Th1) cytokines (IFN-gamma) and Th2 cytokines (IL-4, IL-5 and IL-10) were significantly 
upregulated in the proximal colons of the OVA mice, an effect which was also reduced by kakkonto. 
Transcriptome analysis detected increased mRNA expression of suppressor of cytokine signaling-3 in the 
proximal colons of OVA mice, which was decreased by kakkonto administration. Conclusion: Kakkonto 
has immunosuppressive effects and interferes with the infiltration of mucosal mast cells in the colons of 
mice with induced food allergy, leading to improvement of allergic symptoms. Kakkonto has potential as a 
therapeutic drug for treatment of allergic symptoms induced by the disruption of intestinal mucosal 
immunity. 
㩷
㩷 2) Kageyama-Yahara N., Suehiro Y., Yamamoto T., Kadowaki M.: IgE-induced degranulation 
of mucosal mast cells is negatively regulated via nicotinic acetylcholine receptors. 
Biochemical and Biophysical Research Communications 377: 321-325, 2008. 
㩷 Abstract: The autonomic nervous system is known to mediate mast cell activation. We investigated 
expression of nicotinic acetylcholine receptors (nAChRs) in mucosal-type mast cells and their 
contribution to the regulation of mast cell activation. Expression of mRNA of nAChR alpha4, alpha7, and 
beta2 subunits were detected in specially differentiated mucosal-type murine bone marrow-derived mast 
cells (mBMMCs). Pretreatment with non-specific nAChRs agonists, acetylcholine, nicotine and 
epibatidine and a specific alpha7 subunit agonist GTS-21 significantly inhibited antigen-induced 
degranulation of mBMMCs in a dose-dependent manner and GTS-21-induced inhibition was significantly 
blocked by alpha7 subunit antagonist, alpha-bungarotoxin. Furthermore, confocal microscopy also 
demonstrated surface binding of alpha-bungarotoxin on mBMMCs. Our findings indicate that mucosal 
mast cell activation may be negatively regulated mainly through nAChR alpha7 subunit, suggesting that 
nAChRs are involved in neuronal-mucosal mast cell interactions 
㩷
㩷 3) Leng Y., Yamamoto T., Kadowaki M.: Alteration of cholinergic, purinergic and sensory 
neurotransmission in the mouse colon of food allergy model. 
Neuroscience Letters 445: 195-198, 2008. 
㩷 Abstract: It is well known that intestinal anaphylaxis results in a disturbed intestinal motility. It is 
hypothesized that the chronic intestinal anaphylaxis-induced changes in the enteric neuronal circuitry 
cause intestinal motor malfunctions. However, detailed mechanisms largely remain unclear. The aim of 
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this study was to investigate the pathophysiological role of ATP, which acts as a non-cholinergic 
neurotransmitter and a neuroimmune modulator, in a disturbed intestinal motility of food allergy (FA). 
The FA mice developed allergic diarrhea accompanied with chronic inflammation and mast cell 
hyperplasia in the colon. The excised proximal colons (PCs) were suspended in the longitudinal direction 
in organ baths. In the PCs precontracted by KCl (50 mM), contractile responses to exogenous ATP (1 mM) 
were significantly (P < 0.01) higher in FA mice (34.2% of KCl-induced precontractions) as compared to 
control mice (17.2%). Pretreatment with P2 purinoceptor antagonists [suramin and PPADs] significantly 
(P < 0.01) reduced the ATP-evoked contractions to 7.7% and 1.5% in FA and control PCs, respectively. 
Furthermore, in the presence of inhibitors of cholinergic nerves and capsaicin-sensitive sensory nerves the 
electrical field stimulation (EFS; 10Hz)-evoked contractions were significantly (P < 0.05) higher in FA 
mice (65.8% of EFS-evoked maximum contractions, n = 6) than those in control mice (47.9%, n = 6). In 
addition, cumulative application of suramin and PPADs further inhibited EFS-induced contractions by 
21.7% in FA mice (n = 6, P < 0.01) and 8.7% in control mice (n = 6, P < 0.05). Thus, the present study 
suggests that the sustained alteration in cholinergic, purinergic and sensory neurotransmission contribute 
to the disturbed motility during the chronic intestinal anaphylaxis. 
㩷
㩷 4) Kadowaki H., Yamamoto T., Kageyama-Yahara N., Kurokawa N., Kadowaki M.: The 
pathophysiological roles of COX-1 and COX-2 in the intestinal smooth muscle contractility 
under the anaphylactic condition. 
Biomedical Research 29: 113-117, 2008.  
㩷 Abstract: Various inflammatory mediators released from antigen-activated mast cells are considered to 
play a key role in the pathogenesis of food allergy. The aim of the present study was to determine the 
mechanisms underlying the antigen-induced anaphylactic responses in the rat colons. Wistar rats were 
sensitized by intraperitoneal injection of ovalbumin (OVA). The contractilities of isolated proximal colons 
of the sensitized rats were studied in the organ bath. OVA challenges of sensitized tissues induced 
prolonged contractile responses. The antigen-induced contractions were greatly reduced by mast cell 
stabilizer doxantrazole (10 microM). However, the contractions were resistant to histamine H1 receptor 
antagonist and prostaglandin D2 receptor antagonist. In contrast, non-selective cyclooxygenase (COX) 
inhibitor indomethacin (1 microM) significantly reduced the contractions by 61.0%. Furthermore, 
selective COX-1 inhibitor FR122047 (10 microM) as well as selective COX-2 inhibitor NS-398 (10 
microM) significantly inhibited the contractions by 50.1% and 50.3%, respectively. Nevertheless, the 
transcript levels of COX-2 as well as COX-1 were not upregulated by OVA in the proximal colons of the 
sensitized rats. The present results indicate that de novo arachidonic acid metabolites synthesis by 
constitutive COX-1 as well as constitutive COX-2 within mast cells contribute to the altered smooth 
muscle contractilities in the colons under the anaphylactic condition. 
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8. 30-31, ᄢ㒋㧚

 ᜗ᓙ⻠Ṷ
 1) 㐷⣁ ⌀㧦ⶄ㔀♽ߢ޽ࠆ⣺▤ߩ఺∉ᕈ∔ᖚߦኻߔࠆⶄว⮎‛ߢ޽ࠆ๺ṽ⮎࡮ṽᣇ⮎߆ࠄ
ߩ⑼ቇ⊛ࠕࡊࡠ࡯࠴㧚
╙  ࿁ᣣᧄ᧲ᵗකቇળർ㒽ᡰㇱᄐቄ⻠Ṷળ㧘 2008, 7. 13, ንጊ㧚
 2) 㐷⣁ ⌀㧦ᶖൻ▤∔ᖚߦ߅ߌࠆṽᣇ⮎ᴦ≮ߩ૏⟎ઃߌ㧚
╙ 13࿁ ንጊᄢቇ ๺ṽක⮎ቇ✚ว⎇ⓥᚲ ᄐᦼ࠮ࡒ࠽࡯ޟ⃻ઍක≮ߩਛߩ๺ṽ⮎ޠ㧘
2008, 8. 6-8, ንጊ㧚
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 3) 㐷⣁ ⌀㧦ⶄ㔀♽ߢ޽ࠆ⣺▤ߩ఺∉ᕈ∔ᖚߦኻߔࠆⶄว⮎‛ߢ޽ࠆ๺ṽ⮎߆ࠄߩ⑼ቇ⊛
ࠕࡊࡠ࡯࠴㧚
ንጊᄢቇ࡮ጘ㒂⮎⑼ᄢቇቇⴚ੤ᵹ࠮ࡒ࠽࡯ޟ⃻ઍ∔ᖚߣ๺ṽ⮎ߩ᨞ߌᯅޠ㧘
2008, 12.13, ንጊ㧚

 ࿖㓙දജ
 1) 㐷⣁ ⌀㧦࿖㓙දജᯏ᭴
,+%#ࡒࡖࡦࡑ࡯વ⛔ක≮ࡊࡠࠫࠚࠢ࠻㧘
2008, 12.6-11, Yangon, Mandalay, Myanmar.  

 ᣂ⡞
 1) ⎇ⓥቶ⊒㧦ᶖൻེᴦ≮ߦṽᣇ⮎ᵴ↪ ንጊᄢቇ๺ṽක⮎ቇ✚ว⎇ⓥᚲ 㐷⣁⌀ᢎ᝼㧚
ਛᣣᣂ⡞㧘2008, 4. 1.
 
 ⎇ⓥળ
 1) 㐷⣁ ⌀㧘ጊᧄ ᱞ㧦'05 ⎇ⓥળ㧘2008,11. 8, ੩ㇺ㧚

٠౒ห⎇ⓥ 
࿖ౝ
1) ⮥ᧄඳผ㧦੩ㇺᎿ⧓❫⛽ᄢቇᄢቇ㒮Ꮏ⧓⑼ቇ⎇ⓥ⑼ᔕ↪↢‛ቇㇱ㐷⚦⢩ᯏ⢻ቇಽ㊁
ޟ⣺▤␹⚻♽ߦ߅ߌࠆㅅ⿛␹⚻෸߮⍮ⷡ␹⚻ᡰ㈩ߦ㑐ߔࠆ⎇ⓥޠ
ޟㅒᵹᕈ㘩㆏Ἳߩ∛ᘒ↢ℂቇ⊛෸߮ᒻᘒቇ⊛⎇ⓥޠ
ޟ⣺▤☼⤑ဳࡑࠬ࠻⚦⢩ߩᒻᘒቇ⊛⎇ⓥޠ
ޟ⣺▤఺∉ᕈ∔ᖚߦ߅ߌࠆ⣺▤␹⚻♽ߩᓎഀߦ㑐ߔࠆ⎇ⓥޠ
2004, 5㧙
2) 㐷⣁ ቁ㧦᧲੩ᄢቇᄢቇ㒮කቇ♽⎇ⓥ⑼ઍ⻢ᩕ㙃∛ᘒቇ㧔♧ዩ∛࡮ઍ⻢ౝ⑼㧕
ޟPPARȖᰳ៊ࡑ࠙ࠬࠍ↪޿ߚ఺∉ቇ⊛⎇ⓥޠ
ޟPI3ࠠ࠽࡯࠯ᰳ៊ࡑ࠙ࠬࠍ↪޿ߚ఺∉ቇ⊛⎇ⓥޠ
2004㧘7㧙
3) ዊ቟㊀ᄦ㧦ᘮᔕ⟵Ⴖᄢቇකቇㇱ఺∉ቇ
ޟPI3ࠠ࠽࡯࠯ᰳ៊ࡑ࠙ࠬࠍ↪޿ߚ఺∉ቇ⊛⎇ⓥޠ
2004, 7㧙
4) ᧲↰ජ዆㧦ንጊᄢቇ๺ṽක⮎ቇ✚ว⎇ⓥᚲ
ޟPI3ࠠ࠽࡯࠯ߩ␹⚻ᄌᕈ∔ᖚ߳ߩ㑐ਈߦ㑐ߔࠆ⎇ⓥޠ
2005, 10㧙
٠⎇ⓥ⾌ขᓧ⁁ᴫ 㩷
㩷 1) ᐔᚑ 20ᐕᐲ ᣣᧄቇⴚᝄ⥝ળ⑼ቇ⎇ⓥ⵬ഥ㊄ ⧯ᚻ (B) ઍ⴫㧦ጊᧄ ᱞ
⎇ⓥ㗴⋡䋺✂⟜⊛ㆮવሶ⊒⃻⸃ᨆ╬䉕↪䈇䈢㘩‛䉝䊧䊦䉩䊷䊝䊂䊦䈮ኻ䈜䉎⪾ᩮḡ䈱
ᴦ≮ᯏᐨ䈱⸃᣿
㩷 2) ᐔᚑ 20ᐕᐲ ⽷࿅ᴺੱ༛ᾍ⑼ቇ⎇ⓥ⽷࿅ ઍ⴫㧦㐷⣁ ⌀
⎇ⓥ⺖㗴㧦ẩ≌ᕈᄢ⣺Ἳࡕ࠺࡞ߦ߅ߌࠆ T ⚦⢩ߢߩǩ7 ဳ࠾ࠦ࠴ࡦฃኈ૕ࠍ੺ߔࠆ࠾ࠦ
࠴ࡦߩ᛫ Th2ဳἻ∝࡮఺∉૞↪ߩಽሶࡔࠞ࠾࠭ࡓߩ⸃᣿
㩷 3)㩷 ᐔᚑ 20ᐕᐲ ⽷࿅ᴺੱ༛ᾍ⑼ቇ⎇ⓥ⽷࿅ ಽᜂ㧦㐷⣁ ⌀
⎇ⓥ⺖㗴㧦༛ᾍߣ⢗㘩㆏ㅒᵹ∝(GERD)⊒∝ߦ㑐ߔࠆ⎇ⓥ㧦․ߦ㧘ታ㛎 GERDࡕ࠺࡞ߢߩ
ਅㇱ㘩㆏᜝⚂╭ߩᛥ೙ᕈ␹⚻࿁〝ߦ߅ߌࠆ࠾ࠦ࠴ࡦฃኈ૕ߩ∛ᘒ↢ℂቇ⊛ᓎഀ㩷
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㩷 4) ᐔᚑ 20ᐕᐲ ጊፒ㚅ㄆᢱᝄ⥝⽷࿅ ઍ⴫㧦㐷⣁ ⌀
⎇ⓥ⺖㗴㧦ධࠕࠫࠕ࿾ၞߩ㚅ㄆᢱߩࡋ࡝ࠦࡃࠢ࠲࡯࡮ࡇࡠ࡝⩶ߦኻߔࠆ᛫⩶૞↪ߩត⚝
⎇ⓥ㩷
㩷 5) ᐔᚑ 20ᐕᐲ ቇ㐳ⵙ㊂⚻⾌ ಽᜂ㧦ጊᧄ ᱞ㧘ᓇጊᄐሶ
⎇ⓥ⺖㗴㧦વ⛔⮎‛ߦࠃࠆ↢૕ᯏ⢻ߩ㕟ᣂ⊛⸃ᨆ߅ࠃ߮ഃ⮎ᚢ⇛㩷
㩷 6) ንጊ⋵ ᐔᚑ 20ᐕᐲฃ⸤⎇ⓥ ๺ṽ⮎࡮ࡃࠗࠝ࠹ࠢࡁࡠࠫ࡯⎇ⓥ ઍ⴫㧦㐷⣁ ⌀
⎇ⓥ⺖㗴㧦఺∉⺞▵૞↪ࠍ᦭ߔࠆ๺ṽ⮎࡮ṽᣇ⮎ߩ⑼ቇ⊛⮎ല⹏ଔߣᣂⷙ๺ṽ⮎⵾೷㐿
⊒
㩷
٠⎇ⓥቶ࿷☋⠪ 㩷
㩷 ⮎ቇㇱ 3ᐕ↢㧦㊄ౝఝ਽㧘᳋⾐Ỉᗲ
㩷 ⮎ቇㇱ 4ᐕ↢㧦ဝ↰ᖘ⌀㧘೨↰ᄥ
㩷 ᄢቇ㒮ඳ჻೨ᦼ 1ᐕ㧦ᧃᑝ㓁ሶ㧘ൎᧁᵗ૓㧘㗇⮮ᷕ⟤㧘᧘࿷ᢅ
㩷 ᄢቇ㒮ඳ჻೨ᦼ 2ᐕ㧦⮮ේട⧣㧘ศ↰⋉ᄹሶ
㩷 ᄢቇ㒮ඳ჻ᓟᦼ 3ᐕ㧦 Syed Faisal Haider Zaidi 
㩷 ⎇ⓥ↢㧦ᷰㄝື㇢㧔ንጊᄢቇᄢቇ㒮කቇ⮎ቇ⎇ⓥㇱ๺ṽ⸻≮ቇ⻠ᐳ㧕
    ㆙㊁㓷ᓼ㧔ᣣᧄቇⴚᝄ⥝ળ․೎⎇ⓥຬ㧕
    Wang Ping㧔Department of Pharmacognosy, Heilongjiang University of Chinese Medicine㧕
㩷
٠ቇ૏㧔ୃ჻㪃㩷ඳ჻㧕ขᓧ⠪ 㩷
㩷 ୃ჻⺰ᢥ
㩷    ቝㇺችᄹⓄ㧦ࡑ࠙ࠬ㘩‛ࠕ࡟࡞ࠡ࡯∛ᘒࡕ࠺࡞ߦ߅ߌࠆ࠾ࠦ࠴ࡦฃኈ૕ߩ∛ᘒ↢ℂቇ⊛
        ᓎഀ
㩷    ా₹೑ዏ㧦ࡑ࠙ࠬ㘩‛ࠕ࡟࡞ࠡ࡯ᕈᶖൻེ∝⁁ߩ⊒∝ߦ߅ߌࠆᶖൻ▤☼⤑ဳࡑࠬ࠻⚦⢩
        ߩ∛ᘒ↢ℂቇ⊛ᓎഀ
㩷
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